25.02.2015 Views

GIDEON KOREN & Co. - GKL

GIDEON KOREN & Co. - GKL

GIDEON KOREN & Co. - GKL

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

“Cures for<br />

Humanity”<br />

September 13,<br />

2011<br />

Legal Pitfalls in Agreements<br />

for the <strong>Co</strong>mmercialization<br />

of Intellectual Property<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

Types of Agreements<br />

Founders’ Agreement<br />

<strong>Co</strong>nfidential Disclosure Agreement<br />

Material Transfer Agreement<br />

MOU<br />

License<br />

Asset Purchase<br />

Joint Venture<br />

Investment Agreement<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

Founders’ Agreement<br />

Role of each founder<br />

Inventor/Financier/Engineer<br />

Share allocation<br />

Dilution in case of further financing<br />

Dilution if party does not perform<br />

Board<br />

On-going management<br />

Effect of termination<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

Starting Up Agreements (1)<br />

CDA-Important for Discloser and<br />

Recipient<br />

Define exactly what is disclosed<br />

Define purpose of disclosure and limit<br />

disclosure to same.<br />

Mutual or one way?<br />

Injunction<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

Starting Up Agreements<br />

(2)<br />

Finder’s Agreement<br />

Exclude prior contacts<br />

Exclusive?<br />

<strong>Co</strong>mmission – cash/options<br />

Termination<br />

“Tail”<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

Material Transfer Agreement<br />

(1)<br />

Transfer of biologic materials for research.<br />

Permitted uses, further distribution,<br />

ownership, liability, publication,<br />

compliance with law, term and any<br />

applicable costs.<br />

Progeny” are essentially unaltered copies<br />

of the Original Material.<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

Material Transfer Agreement<br />

(2)<br />

Unmodified Derivatives: “Substances<br />

created by the Recipient which constitute<br />

an unmodified, functional subunit or<br />

product expressed by the Original<br />

Material<br />

Modifications: “Substances created by<br />

the Recipient which contain/incorporate<br />

the Material.<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

Material Transfer Agreements<br />

(3)<br />

Provider will usually retain ownership to IP,<br />

Progeny and Unmodified Derivatives.<br />

Recipient will own Modifications, but<br />

cannot distribute commercially without a<br />

license.<br />

Provider may seek license to use<br />

Modifications.<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

MOU<br />

<strong>Co</strong>mmon use by commercial arms of<br />

universities, etc.<br />

Serves as a type of term sheet<br />

Lays out what shall be the terms of the<br />

license<br />

Leaves out substantive terms such as<br />

indemnification<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

License Agreements (1)<br />

Worldwide, perpetual, exclusive, royalty free<br />

Royalty bearing (only till end of patent term)<br />

Lump sum/periodic/income or milestone<br />

dependent<br />

“In the event that the Products are not<br />

protected under a valid claim of the Patent in<br />

any country, then the aforesaid royalty in<br />

respect of sales in such country shall be<br />

reduced to 2.4% and 3.2%, respectively.”<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

License Agreements (2)<br />

Sublicenses<br />

Royalties on sub-licenses<br />

Improvements<br />

“Anti Stacking”<br />

Reach Through Royalties<br />

Patent Prosecution<br />

Indemnification<br />

Grant back/cross licenses<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

Sale of Intellectual Property<br />

Advantages/disadvantages<br />

Lump Sum<br />

Royalties<br />

Parties<br />

www.gkl.co.il


<strong>GIDEON</strong> <strong>KOREN</strong> & <strong>Co</strong>.<br />

LAW OFFICES & NOTARY<br />

Thank you for your attention and<br />

participation.<br />

www.gkl.co.il

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!